Atlas Trials

A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil

Clinical trial NCT07199946 · RECRUITING

Trial details

NCT number
NCT07199946
Sponsor
Johnny Ludvigsson
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2025-08-06
Primary completion
2029-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.